A Duchenne gene therapy faces a crucial test, while highly anticipated study results lay ahead in lung cancer, obesity and heart disease.The next six months will be full of dramatic moments for the biotechnology industry.The Food and Drug Administration will either be validated or undermined for its decision to grant an early approval to the […]
